Medical Communications
FDA approves ANDA of 20mg generic Nitisinone capsules
June 1, 2023 Medical Communications Analog Pharma, Dipharma, FDA, Nitisinone, Rare Diseases
Lonza to acquire Synaffix to strengthen ADC development
June 1, 2023 Medical Communications ADC, Lonza, Oncology, Synaffix, drug development
Bristol Myers Squibb’s NDA accepted by FDA
May 31, 2023 Medical Communications FDA, NDA, NSCLC, Oncology, bristol myers squibb
Pulse Medical receives FDA BDD for its μFR system
May 30, 2023 Medical Communications BDD, Cardiology, FDA, Pulse Medical
AstraZeneca’s Ultomiris approved in Japan for prevention of relapses in patients with NMOSD
May 30, 2023 Medical Communications AstraZeneca, NMOSD, Neurology, Ultomiris
FDA approves first oral antiviral to treat adult patients with COVID-19
May 26, 2023 Medical Communications COVID-19, FDA, Infections and infestations, paxlovid
ZOLL remedē System receives FDA approval for sleep apnoea treatment
May 25, 2023 Medical Communications Ear Nose & throat, FDA, ZOLL, sleep apnoea
AstraZeneca shares oncology data at ASCO 2023
May 25, 2023 Medical Communications ASCO, AstraZeneca, Cancer, Oncology, oncology
Artivion receives FDA PMA approval of PerClot; transfers designation to Baxter
May 24, 2023 Medical Communications Artivion, Baxter International, Cardiology, FDA, PMA, PerClot
FDA approves Innoviva’s Xacduro for intravenous use
May 24, 2023 Medical Communications FDA, Infections and infestations, Innoviva, pneumonia
Rocket Pharmaceuticals granted FDA RMAT designation for gene therapy
May 24, 2023 Medical Communications FDA, Haematology, RMAT, Rocket Pharmaceuticals, gene therapy
More infections from contaminated eyedrops increase death toll
May 23, 2023 Medical Communications FDA, Opthalmology, eyedrops, infections
Grünenthal receives FDA Breakthrough Therapy Designation for knee osteoarthritis drug
May 23, 2023 Medical Communications Breakthrough Therapy Designation, FDA, Grunenthal, Musculo-skeletal disorder, osteoarthritis
FDA approves prescription nasal spray for opioid overdose treatment
May 23, 2023 Medical Communications FDA, Nasal Spray, Opvee, Poisoning and drug dependency, opioids, overdose
FDA approves new insulin pump and algorithm software for enhanced automated insulin delivery
May 22, 2023 Medical Communications Devices, FDA, diabetes, insulin
Latest content
